Synapse - Dean Bajorin

Results (663)

A comparison of toxicity of gemcitabine versus platinum-based combined chemoradiation for muscle-invasive bladder cancer: The Memorial Sloan-Kettering experience

Meeting Abstract

Baliga, S.; Pei, X.; Bajorin, D. F.; Rosenberg, J. E.; Bochner, B.; Kollmeier, M.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Peroxisome proliferator-activated receptor gamma (PPARG) gene amplifications in urothelial carcinoma (UC)

Meeting Abstract

Bambury, R. M.; Iyer, G.; Riester, M.; Werner, L.; Schultz, N.; Stack, E. C.; Park, R.; Loda, M.; Ostrovnaya, I.; Kantoff, P. W.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Preliminary HER2 expression data from NeuACT, the phase II randomized, open-label trial of DN24-02 in patients (pts) with surgically resected HER2+ urothelial cancer (UC) at high risk for recurrence

Meeting Abstract

Press, M. F.; O'Donnell, P. H.; Plimack, E. R.; Hoffman-Censits, J. H.; Quinn, D. I.; Sharma, P.; DeVries, T.; Chen, M.; Locker, M.; Bajorin, D. F.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Phase I/II study of paclitaxel plus ifosfamide (TI) followed by high-dose paclitaxel, ifosfamide, and carboplatin (TIC) with autologous stem cell transplant (ASCT) for salvage treatment of germ cell tumors (GCT)

Meeting Abstract

Jia, X.; Feldman, D. R.; Glezerman, I.; Van Alstine, L. J.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M. S.; Reich, L.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Paclitaxel, ifosfamide, and cisplatin (TIP) efficacy for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)

Meeting Abstract

Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Preliminary safety, product parameters, and immune response assessments from a phase II randomized, open-label trial of DN24-02, an autologous cellular immunotherapy (ACI), in patients (pts) with surgically resected HER2+ urothelial cancer (UC) at high risk for recurrence

Meeting Abstract

Bajorin, D. F.; Sharma, P.; Lerner, S. P.; Sims, R. B.; Sanders, A.; DeVries, T.; Sheikh, N. A.; Gomella, L. G.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

HER2 tissue expression in NeuACT, a phase 2, randomised, open-label trial of DN24-02 in patients (pts) with surgically resected HER2+ urothelial cancer (UC) at high risk for recurrence

Meeting Abstract

Press, M. F.; O'Donnell, P. H.; Plimack, E. R.; Hoffman-Censits, J.; Quinn, D. I.; Sharma, P.; DeVries, T.; Chen, M.; Locker, M.; Bajorin, D. F.
European Journal of Cancer (2013)

Fulltext@MSK | Save

NeuACT, a Phase 2 randomised, open-label trial of DN24-02 in patients (pts) with surgically resected HER2+ urothelial cancer (UC) at high risk for recurrence: Updated analysis of product parameters and safety

Meeting Abstract

Bajorin, D.; Sharma, R.; O'Donnell, P. H.; Sims, R.; DeVries, T.; Sheikh, N.; Gomella, L. G.
European Journal of Cancer (2013)

Fulltext@MSK | Save

Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer

Journal Article

Iyer, G.; Al-Ahmadie, H.; Schultz, N.; Hanrahan, A. J.; Ostrovnaya, I.; Balar, A. V.; Kim, P. H.; Lin, O.; Weinhold, N.; Sander, C.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: The role of the host

Journal Article

Gallagher, D. J.; Vijai, J.; Hamilton, R. J.; Ostrovnaya, I.; Iyer, G.; Garcia-Grossman, I. R.; Kim, P. H.; Przybylo, J. A.; Alanee, S.; Riches, J. C.; more...
Annals of Oncology (2013)

Fulltext@MSK | Save